A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
While the evidence bases for both CMs and Schedule 3 sleep aids are unlikely to immediately change, a core practice consideration is the risk-benefit profile of the respective non-prescription sleep aids for the individual patient. 
Is it really insomnia?
Knowledge to practice 
Healthcare highway: Pharmacists in the driver’s seat
Australia’s National Digital Health Strategy has outlined a five-year transition to a digitally connected health system, beginning with opt-out My Health Records for every...
What is your 10 Year Vision?
Internationally, models of care delivered by pharmacists show significant impact in terms of better health outcomes, reduced costs to healthcare systems, and achieving full...
The role of pharmacists in home-based palliative care
While the majority of Australian palliative care patients want to be cared for and die at home, less than 10 per cent achieve that...
Through crisis comes strength and reform
The COVID-19 pandemic continues to challenge us all every day. It challenges us to adjust to new ways of living. Crisis is often a catalyst for change.
Pharmacists key to respiratory health in extreme weather
The recent dust storms and bushfires in NSW and Queensland serve as a reminder of the escalating effects of climate change, leading to an...
‘Don’t you know who I am?’: Why patient identification is so...
When we think patient safety, pharmacists’ minds jump to drug interactions, adverse events or toxic doses. But incorrect patient identification can have equal capacity...
